Abstract 5511: Frontline therapy with anti-PD1 enhances the durability of combination targeted therapy in <i>NRAS</i>-mutant melanoma

Authors: Manali S. Phadke, Zhihua Chen, Eslam Mohamed, Michael Davies, Ann Chen, Uwe Rix, Paulo Rodriguez, Keiran Smalley

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-5511

Source: Full article